We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
At the forefront of innovation in the international pharmaceutical market, Leon-Nanodrugs is leading the way in supergenerics and high-barrier generics. Dr Wolfgang Beier, managing director at the company, answers World Pharmaceutical Frontiers’ questions.